4
Changes in Ownership
ANI PHARMACEUTICALS INC Filed Acc 0001104659-23-083131
HEAD OF R&D, COO-NOVITIUM OPS sold 23,469 shares at an average $52.02 ($1,220,844)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Shanmugam Muthusamy · HEAD OF R&D, COO-NOVITIUM OPS
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-19 | Sale : show line 1 in the form 10b5-1 | −5,969 | $51.48 | $307,284 | 1,250,120 | I |
| 2023-07-20 | Sale : show line 2 in the form 10b5-1 | −6,000 | $51.52 | $309,120 | 1,244,120 | I |
| 2023-07-21 | Sale : show line 3 in the form 10b5-1 | −11,500 | $52.56 | $604,440 | 1,232,620 | I |
| Open-market sales · 23,469 sh · avg $52.02 · $1,220,844 | ||||||
Loading xslF345X05/tm2321830-1_4seq1.xml…